InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.03
(
0.61%
)
US TECH 100
19,700.00
(
-0.02%
)
Dow Jones
42,863.86
(
0.97%
)
Brent Oil
78.70
(
0.00%
)
Bitcoin
63,009.52
(
0.89%
)
Post# of 253348
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

io_io

Send PM Follow Ignore
Followers 64
Posts 5557
Boards Moderated 0
Alias Born 01/17/2005

io_io

Re: spartex post# 18513

Tuesday, 11/15/2005 9:29:06 AM

Tuesday, November 15, 2005 9:29:06 AM

Post# of 253348
CEGE:

"The one-year survival was 88% and the two-year survival was 76%, with a mean follow-up of approximately 24 months. "

I know it's only a Phase II, but that's pretty good stuff for Pancreatic Cancer - I think median survival is among the shortest of all cancers.

"....on the biotech battle-field, you need some élan...."

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up